End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-22 pm EDT
|
5-day change
|
1st Jan Change
|
2.6
CNY
|
+0.78%
|
|
+6.56%
|
-8.13%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,298
|
2,798
|
1,361
|
2,330
|
2,103
|
5,544
|
Enterprise Value (EV)
1 |
4,202
|
2,930
|
1,814
|
2,747
|
2,538
|
4,777
|
P/E ratio
|
-4.03
x
|
-2.74
x
|
-4.5
x
|
-2.28
x
|
-1.32
x
|
3.18
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
4.55
x
|
4.78
x
|
3.18
x
|
5.99
x
|
3.34
x
|
12.7
x
|
EV / Revenue
|
5.8
x
|
5
x
|
4.24
x
|
7.06
x
|
4.03
x
|
10.9
x
|
EV / EBITDA
|
-21
x
|
-4.13
x
|
-7.19
x
|
-4.3
x
|
-3.65
x
|
-183
x
|
EV / FCF
|
-4.2
x
|
2.58
x
|
-3.85
x
|
9.07
x
|
6.97
x
|
-8.47
x
|
FCF Yield
|
-23.8%
|
38.8%
|
-25.9%
|
11%
|
14.3%
|
-11.8%
|
Price to Book
|
1.2
x
|
1.61
x
|
0.95
x
|
5.68
x
|
-1.8
x
|
9.87
x
|
Nbr of stocks (in thousands)
|
756,350
|
756,350
|
756,350
|
756,350
|
756,350
|
1,958,947
|
Reference price
2 |
4.360
|
3.700
|
1.800
|
3.080
|
2.780
|
2.830
|
Announcement Date
|
4/29/19
|
6/29/20
|
4/29/21
|
4/29/22
|
4/28/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
725
|
585.6
|
428
|
389
|
629.3
|
437.2
|
EBITDA
1 |
-199.9
|
-709.7
|
-252.4
|
-638.9
|
-695.7
|
-26.16
|
EBIT
1 |
-298.8
|
-820.8
|
-353.5
|
-738.1
|
-787.6
|
-119.3
|
Operating Margin
|
-41.21%
|
-140.16%
|
-82.6%
|
-189.77%
|
-125.15%
|
-27.28%
|
Earnings before Tax (EBT)
1 |
-790.4
|
-1,029
|
-299.5
|
-1,019
|
-1,573
|
1,746
|
Net income
1 |
-788.2
|
-1,021
|
-299.4
|
-1,019
|
-1,585
|
1,750
|
Net margin
|
-108.71%
|
-174.36%
|
-69.96%
|
-262.05%
|
-251.85%
|
400.15%
|
EPS
2 |
-1.083
|
-1.350
|
-0.4000
|
-1.350
|
-2.100
|
0.8900
|
Free Cash Flow
1 |
-999.5
|
1,137
|
-470.7
|
302.8
|
364
|
-563.8
|
FCF margin
|
-137.85%
|
194.21%
|
-109.98%
|
77.84%
|
57.83%
|
-128.95%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/29/19
|
6/29/20
|
4/29/21
|
4/29/22
|
4/28/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
904
|
132
|
453
|
418
|
436
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
767
|
Leverage (Debt/EBITDA)
|
-4.523
x
|
-0.1857
x
|
-1.794
x
|
-0.6539
x
|
-0.6261
x
|
-
|
Free Cash Flow
1 |
-999
|
1,137
|
-471
|
303
|
364
|
-564
|
ROE (net income / shareholders' equity)
|
-27.4%
|
-45.5%
|
-18.8%
|
-109%
|
432%
|
738%
|
ROA (Net income/ Total Assets)
|
-4.55%
|
-13%
|
-6.29%
|
-15.6%
|
-21.1%
|
-3.17%
|
Assets
1 |
17,327
|
7,872
|
4,761
|
6,554
|
7,495
|
-55,262
|
Book Value Per Share
2 |
3.640
|
2.290
|
1.890
|
0.5400
|
-1.540
|
0.2900
|
Cash Flow per Share
2 |
0.0800
|
1.140
|
0.3500
|
0.3000
|
0.1700
|
0.2300
|
Capex
1 |
143
|
32.3
|
41.8
|
22.4
|
30
|
15.6
|
Capex / Sales
|
19.74%
|
5.52%
|
9.76%
|
5.76%
|
4.76%
|
3.57%
|
Announcement Date
|
4/29/19
|
6/29/20
|
4/29/21
|
4/29/22
|
4/28/23
|
4/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -8.13% | 698M | | -5.86% | 12.09B | | -4.87% | 8.21B | | +5.47% | 5.74B | | +27.42% | 5.64B | | -9.89% | 4.16B | | -58.99% | 2.88B | | +8.97% | 2.69B | | -5.19% | 2.33B | | +21.58% | 2.17B |
Diagnostic & Testing Substances
|